Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience.

Nikita ChhabraCarolyn Mead-HarveyChristopher A DodooCourtney IserHallie TaylorHira ChaudharyAimen VanoodDavid W Dodick

Published in: Headache (2024)

We found that 23.3% of patients initiated on erenumab may have developed worsening BP, suggesting the need for BP monitoring in patients initiated on erenumab.

Keyphrases

end stage renal disease
newly diagnosed
blood pressure
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
adipose tissue
heart rate
skeletal muscle
weight loss